Skip to content

About
News
Clinicians
Patients
Research

About
News
Clinicians
Patients
Research

RVO Publications

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

Outliers of Treatment Frequency in Retinal Vein Occlusion: 24-Month Comparative Analysis of Fight Retinal Blindness! Practitioners

Clinical & Experimental Ophthalmology

, (epub)

December 2024

Impact of cataract surgery on patients receiving intravitreal therapy for retinal vein occlusion

Clinical & Experimental Ophthalmology

, (epub)

December 2024

Three-year outcomes of vascular endothelial growth factor inhibitors in naïve branch retinal vein occlusion: Fight Retinal Blindness!

Ophthalmology. Retina

October 2024

Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry

Scientific Reports

, (epub)

March 2024

Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

British Journal of Ophthalmology

June 2023

Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion

Eye

April 2023

One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion

Clinical and Experimental Ophthalmology

December 2022

Central retinal vein occlusion 36-month outcomes with anti-vascular endothelial growth factors: the Fight Retinal Blindness! registry

Ophthalmology. Retina

November 2022

Incidence, Risk Factors and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor for Retinal Diseases: Data from the Fight Retinal Blindness! Registry

Ophthalmology Retina

November 2022

Twelve-month treatment outcomes of macular edema following central retinal vein occlusion using aflibercept or ranibizumab in routine clinical practice – data from the Fight Retinal Blindness! project

Acta Ophthalmologica

June 2022

12-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry

British Journal of Ophthalmology

June 2022

Quality of life impact of eye diseases: a Save Sight Registries study

Clinical and Experimental Ophthalmology

May 2022

« Previous Page1 Page2 Next »

Email: ssi.ssr@sydney.edu.au
Phone: (+61) 421 787 808

Level 1, South Block
Sydney Eye Hospital
8 Macquarie Street
Sydney NSW 2000

Follow us

X-twitter Facebook Youtube

Quick links

Contact Us
Donate Now

Contact Us
Donate Now